Gilead Sciences
GILD
#134
Rank
C$230.22 B
Marketcap
C$185.67
Share price
1.80%
Change (1 day)
22.38%
Change (1 year)

Earnings for Gilead Sciences (GILD)

Earnings in 2026 (TTM): C$14.80 Billion

According to Gilead Sciences's latest financial reports the company's current earnings are C$29.73 Billion. In 2025 the company made an earning of C$13.65 Billion, an increase over its 2024 earnings that were of C$0.96 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Gilead Sciences from 1991 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) C$14.80 B8.44%
2025 C$13.65 B1319.86%
2024 C$0.96 B-89.94%
2023 C$9.56 B17.97%
2022 C$8.10 B-29.77%
2021 C$11.53 B395.99%
2020 C$2.32 B-67.66%
2019 C$7.19 B-33.84%
2018 C$10.87 B-42.35%
2017 C$18.85 B-20.87%
2016 C$23.82 B-21.06%
2015 C$30.18 B45.8%
2014 C$20.70 B253.01%
2013 C$5.86 B16.51%
2012 C$5.03 B-1.07%
2011 C$5.08 B-6.71%
2010 C$5.45 B11.75%
2009 C$4.88 B29.5%
2008 C$3.76 B19.11%
2007 C$3.16 B-455.74%
2006 -C$0.89 Billion-154.93%
2005 C$1.61 B76.99%
2004 C$0.91 B-266.16%
2003 -C$0.56 Billion-638.24%
2002 C$0.10 B31.5%
2001 C$77.79 M-242.15%
2000 -C$54.74 Million-40.2%
1999 -C$91.52 Million31.85%
1998 -C$69.42 Million8.73%
1997 -C$63.84 Million27.22%
1996 -C$50.18 Million
1994 -C$47.81 Million26.57%
1993 -C$37.78 Million46.49%
1992 -C$25.79 Million362.5%
1991 -C$5.58 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
C$36.20 B 142.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
C$14.76 B-1.28%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
C$8.32 B-44.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
C$43.38 B 190.13%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
C$12.66 B-15.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
C$2.26 B-84.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
C$1.61 B-89.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
C$7.05 B-52.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
C$18.33 B 22.60%๐Ÿ‡บ๐Ÿ‡ธ USA